Chinese Scientists Reveal: 50% of Adults Obese, Dietary Patterns Trigger Health Crisis
Chinese scientists have proposed a regionally specific dietary pattern that they stress is essential to improve the eating habits of the country's population and an effective way to preserve natural and environmental resources amid the rising prevalence of obesity and lifestyle-related diseases.
Last October, China issued its first standardized guidelines for the diagnosis and treatment of obesity. More than half of China's adult population is already overweight or obese, and this trend is expected to continue to grow. The Government has made it clear that a healthy diet is important for the treatment and prevention of obesity.
The team at Sun Yat-sen University's School of Public Health in the economically prosperous southern city of Guangzhou noted that their study followed the principles of a "healthy diet for the planet" and advocated reducing the intake of dairy products and red meat.
The study was published in August in the journal Nature Food and reported by state media last week. The study suggests that residents in northern China, where dairy consumption is high and vegetable intake is low, should increase their intake of fruits and whole grains.
The study also pointed out that in southwest China, where environmental conditions are harsher and water resources are extremely scarce, the region should focus on increasing the intake of beans and vegetables, rather than the current high consumption of red meat.
In the eastern region, where agricultural culture is rich and aquaculture is developed, residents are advised to increase their intake of whole grains, seafood and vegetables.
China's health commission has not yet responded to queries.
Yan Liu, one of the co-authors of the study, said that the recommended dietary pattern helps prevent obesity and cardiac metabolic diseases, adding that it helps reduce the risk of early death and disability, while ensuring that residents' nutritional needs are met.
In their study, the scientists suggested that not only China, but also other developing countries facing similar health and environmental challenges could benefit from this dietary pattern.
Brent Loken, chief scientist for global food at the World Wildlife Fund, said the study offered a promising path forward for developing countries, including India and Kenya.
"Adopting these variants of the global healthy diet can serve as a viable strategy for the transformation of the Chinese diet to achieve the goals of human health and environmental sustainability... Our lessons can be replicated in other countries."
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Novartis Boosts 2025 Earnings Forecast as US Tariff Risks Loom $23 Billion Investment and $10 Billion Buyback Unveiled
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
McKinsey Pays to Close a Purdue Liability Chapter
Recommend Reading
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
-
Roche Keeps German Diagnostics Investment
-
Cost Relaxation, Butylenes Market in Downward Trend
-
Melamine Prices Surge Over 10% as Upstream and Downstream Competition Intensifies in China
-
Strong Supply and Demand Driving Lithium Carbonate Price Fluctuations
-
Supply and Demand Dynamics Continue, Formic Acid Prices Rise
-
Supply Contraction Keeps Raw Materials Firm; PP Market Prices Remain High and Continue to Rise